Circulating suPAR in autoimmune liver diseases: advancing global noninvasive fibrosis and immune profilingon May 16, 2026 at 5:31 am
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Rajesh Prasad Jayaswal
Journal
Closing the evidence gap: Capillary high-sensitivity troponin I verification in an African population using point of careon May 16, 2026 at 5:31 am
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Maseti Amvuyele Ann, Jacob Doreen, Khoza Siyabonga, Chikomba Chemedzai
Reply to: Personalized reference intervals based on biological variation: a critical evaluation of strengths and limitationsWerner Wosniokon May 10, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0554. Online ahead of print. NO ABSTRACT PMID:42107068 | DOI:10.1515/cclm-2026-0554
A model to increase automation and support reliable interpretation of clinical chemistry testsAlessandra Faldaon May 10, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2025-1727. Online ahead of print. ABSTRACT OBJECTIVES: Pathological conditions may result in clinical chemical values exceeding the linearity range of laboratory methods. In clinical practice, not all tests require exact numerical values for patient management, as useful information can still be provided when results are reported to … Read more
Rethinking atherogenic risk: is apolipoprotein B a better biomarker?Giuseppe Lippion May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0624. Online ahead of print. NO ABSTRACT PMID:42106163 | DOI:10.1515/cclm-2026-0624
Limitations to the development of Milan model 1b analytical performance specificationsGraham Ross Dallas Joneson May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0377. Online ahead of print. ABSTRACT A widely accepted approach to setting Analytical Performance Specifications (APS) in laboratory medicine is the Milan models. Milan model 1b is an approach where APS are developed based on patient classification, or clinical decision-making, noting that these factors link to the … Read more
Factors associated with analytical errors in blood chemistry testsHyunjung Kimon May 9, 2026 at 10:00 am
Clin Chem Lab Med. 2026 May 11. doi: 10.1515/cclm-2026-0153. Online ahead of print. ABSTRACT OBJECTIVES: Few studies have systematically evaluated the factors contributing to laboratory errors in the analytical phase. This study analyzed five years of retest data to determine the frequency and characteristics of analytical errors across routine blood chemistry parameters, identify analytes most … Read more
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritison May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Hiroki Kobayashi, Yusuke Murata, Yurie Akiya, Tomomi Matsuoka, Hiromasa Otsuka, Akiko Tsunemi, Yoshihiro Nakamura, Masaki Azuma, Masanori Abe
Exploring the role of circulating glial fibrillary acidic protein and neurofilament light chain in myasthenia gravison May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Caterina Maria Gambino, Luisa Agnello, Concetta Scazzone, Martina Tamburello, Anna Masucci, Roberta Vassallo, Vincenzo Di Stefano, Filippo Brighina, Marcello Ciaccio
Chemical and biochemical derivates of trans-3-methylglutaconyl CoA: A molecular labyrinthon May 11, 2026 at 2:32 pm
Publication date: 15 August 2026 Source: Clinica Chimica Acta, Volume 590 Author(s): Elizabeth A. Jennings, Dylan E. Jones, Robert O. Ryan